Edwards Lifesciences (EW) Tops Q4 EPS by 3c
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $85.88 -1.69%
Revenue Growth %: +11.1%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.1%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.64, $0.03 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.33 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AXT appoints Tracy Liu to its board of directors
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
